/OFIX

Orthofix Medical Inc

OFIX

$8.93USD↑+2.76%+0.24 today

MARKET CAP

363.7M

P/E (TTM)

—

FWD P/E

—

DAY RANGE

$9 – $9

52W RANGE

$9

$17

AI Summary

Stalk

TrimMedium

The asset remains in a Stage 4 decline with confirmed lower highs and lower lows under declining EMAs. Price has been rejected at the 9/20 EMA band repeatedly, reinforcing a medium-term bearish bias. Oversold status does not grant mean-reversion permission, and short-term timing is neutral. Execution should be deferred into future rally attempts into EMA resistance rather than sold immediately. A Trim is recommended to seek a better entry point on a bounce into the EMAs.

↑Q2 EPS of $0.07 beats est; revenue $210.9M (+4% YoY).
↑Global Spine Fixation and Limb Reconstruction segments up double digits.
↓Q2 net loss widened to $15.8M despite revenue gains.

Full analysis →

Buying

3

institutions

Selling

7

institutions

New Positions

1

this quarter

Filing Period

Q2 2026

latest 13-F

13-F Holdings

Institution↕	Action↕	Shares Held↕	Value↓	Change↕	Chg %↕	Weight↕
BI Blackrock, Inc. Q2 2026	BUY	3.33 M	30.40 M	+118.77 K	-17.4%	0.00%
AC Aqr Capital Management LLC Q2 2026	BUY	887.28 K	8.11 M	+698.16 K	+273.9%	0.00%
MM Millennium Management LLC Q2 2026	SELL	862.03 K	7.88 M	+-204.87 K	-35.6%	0.00%
JC Jpmorgan Chase & Co Q2 2026	SELL	164.87 K	1.60 M	+-25.50 K	-25.9%	0.00%
RT Renaissance Technologies LLC Q2 2026	SELL	96.79 K	884.67 K	+-5.20 K	-24.4%	0.00%
MC Moore Capital Management, LP Q2 2026	BUYNEW	85.42 K	780.75 K	+85.42 K	+0.0%	0.01%
PA Point72 Asset Management, L.P. Q2 2026	SELL	73.02 K	667.41 K	+-85.86 K	-63.4%	0.00%
CA Citadel Advisors LLC Q2 2026	SELL	49.42 K	451.68 K	+-76.98 K	-68.8%	0.00%
BH Brevan Howard Capital Management LP Q2 2026	SELL	0.00	0.00	+-28.57 K	-100.0%	0.00%
BA Balyasny Asset Management L.P. Q2 2026	SELL	0.00	0.00	+-28.05 K	-100.0%	0.00%